Answers are grounded in this paper and cite their sources.
Papillary renal cell carcinoma is the second most common histological type of renal cell carcinoma with distinct cytogenetics, histology and prognosis. It exhibits significantly poorer response to molecular targeted therapies, which are about the progress in clear cell carcinoma. We present an overview of the treatment trials and report a casuistic case of metastatic disease controlled for several years with pazopanib.
No takes yet. Share an insight, caveat, or question.
Buraczewska et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: